State Street’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.4M | Buy |
|
|||||
|
2025
Q1 | $5.29M | Sell |
|
|||||
|
2024
Q4 | $5.98M | Buy |
|
|||||
|
2024
Q3 | $5.81M | Buy |
|
|||||
|
2024
Q2 | $5.7M | Buy |
|
|||||
|
2024
Q1 | $6.78M | Buy |
|
|||||
|
2023
Q4 | $4.97M | Buy |
|
|||||
|
2023
Q3 | $4.52M | Sell |
|
|||||
|
2023
Q2 | $5.73M | Sell |
|
|||||
|
2023
Q1 | $6.24M | Sell |
|
|||||
|
2022
Q4 | $9.32M | Buy |
|
|||||
|
2022
Q3 | $10.8M | Buy |
|
|||||
|
2022
Q2 | $12.8M | Sell |
|
|||||
|
2022
Q1 | $13.5M | Sell |
|
|||||
|
2021
Q4 | $20.8M | Buy |
|
|||||
|
2021
Q3 | $38.7M | Buy |
|
|||||
|
2021
Q2 | $20.7M | Buy |
|
|||||
|
2021
Q1 | $17.6M | Buy |
|
|||||
|
2020
Q4 | $9.3M | Buy |
|